Global X Genomics & Biotechnology ETF (GNOM)
GNOM is a passive ETF by Global X tracking the investment results of the Solactive Genomics Index. GNOM launched on Apr 5, 2019 and has a 0.50% expense ratio.
ETF Info
US37954Y4347
37954Y434
Apr 5, 2019
North America (U.S.)
1x
Solactive Genomics Index
Multi-Cap
Growth
Expense Ratio
GNOM features an expense ratio of 0.50%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Global X Genomics & Biotechnology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Global X Genomics & Biotechnology ETF had a return of -14.43% year-to-date (YTD) and -13.05% in the last 12 months.
GNOM
-14.43%
0.71%
-4.90%
-13.05%
-9.16%
N/A
^GSPC (Benchmark)
24.34%
0.23%
8.53%
24.95%
13.01%
11.06%
Monthly Returns
The table below presents the monthly returns of GNOM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -6.99% | 11.44% | -5.01% | -13.44% | 3.05% | 2.86% | 11.40% | -2.15% | -1.14% | -7.73% | 4.43% | -14.43% | |
| 2023 | 7.35% | -7.00% | -2.45% | -0.49% | -0.33% | -0.82% | 1.24% | -8.48% | -9.44% | -12.98% | 17.69% | 10.96% | -8.63% |
| 2022 | -18.69% | -4.21% | -2.78% | -15.24% | -5.81% | 1.83% | 16.53% | -2.88% | -9.26% | 4.78% | 2.66% | -6.30% | -36.27% |
| 2021 | 5.05% | -3.76% | -5.86% | 0.13% | -4.49% | 15.77% | -7.87% | 5.19% | -8.21% | -3.21% | -3.78% | -3.70% | -15.93% |
| 2020 | -6.95% | -1.03% | -13.33% | 16.59% | 13.64% | 6.37% | 0.32% | 0.65% | 1.41% | 0.45% | 16.44% | 12.47% | 51.51% |
| 2019 | -6.71% | -7.10% | 13.51% | -1.05% | -8.31% | -8.84% | 5.65% | 18.49% | -0.29% | 1.56% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of GNOM is 6, meaning it’s performing worse than 94% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Global X Genomics & Biotechnology ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.01 | $0.03 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.04% | 0.14% |
Monthly Dividends
The table displays the monthly dividend distributions for Global X Genomics & Biotechnology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 |
| 2020 | $0.03 | $0.03 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X Genomics & Biotechnology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X Genomics & Biotechnology ETF was 68.54%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current Global X Genomics & Biotechnology ETF drawdown is 64.53%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.54% | Feb 9, 2021 | 685 | Oct 27, 2023 | — | — | — |
| -35.36% | Dec 26, 2019 | 57 | Mar 18, 2020 | 42 | May 18, 2020 | 99 |
| -21.6% | Apr 11, 2019 | 121 | Oct 2, 2019 | 40 | Nov 27, 2019 | 161 |
| -14.38% | Jul 21, 2020 | 35 | Sep 8, 2020 | 21 | Oct 7, 2020 | 56 |
| -9.15% | Oct 14, 2020 | 13 | Oct 30, 2020 | 8 | Nov 11, 2020 | 21 |
Volatility
Volatility Chart
The current Global X Genomics & Biotechnology ETF volatility is 9.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.